LHDX / Lucira Health, Inc. (LHDX) CEO Erik Engelson on Q1 2022 Results - Earnings Call Transcript

Lucira Health (NASDAQ: LHDX ) stock is falling on Friday after the company's shares have seen extreme volatility throughout the week. That includes a more_horizontal

Lucira Health Inc shares have added more than 300% after it announced on Friday that the US Food and Drug Administration (FDA) has granted emergency more_horizontal

Lucira Health (NASDAQ: LHDX ) stock is rocketing higher on Monday thanks to an update from the FDA. The big news here is Lucira Health getting FDA app more_horizontal

Lucira Health Inc. LHDX, +13.45% shares more than doubled in the extended session Friday after the Food and Drug Administration authorized use of its more_horizontal

Lucira Health (NASDAQ: LHDX ) stock is taking a beating on Thursday after the company filed for Chapter 11 bankruptcy protection. To go along with tha more_horizontal

One of the biggest upside movers in today's upside-down market is medical technology company Lucira Health (NASDAQ: LHDX ). This little-known maker o more_horizontal

Lucira Health, Inc. (NASDAQ:LHDX ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Greg Chodaczek – Gilmartin Gro more_horizontal

Lucira Health, Inc. (NASDAQ:LHDX ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group, IR Er more_horizontal